®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
March 31, 2016
Bloom Burton’s analyst David Martin speaks to BNN about Concordia's latest earnings
Click on the image to view the full video.
RELATED NEWS
See All News
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
Bloom Burton & Co. Announces the 2026 Bloom Burton Award
Conavi Medical Corp. Announces Closing of $12M Public Offering
LSL Pharma Group Announces Closing of $12M Private Placement
PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering
Cybin Announces $175 Million Registered Direct Offering
Oliver Technow Receives the 2025 Bloom Burton Award
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
Three Finalists Announced for the 2025 Bloom Burton Award
Conavi Medical Corp. Announces Closing of $20M Public Offering
